Evolent Health

EVH · NYSE

$4.87+$0.39 (+8.71%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $4.48

Latest news

Press releaseOct 9, 4:30 PM ETPRNewswire
Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Press releaseSep 21, 10:01 AM ETPRNewswire
TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
Press releaseSep 21, 10:00 AM ETGlobe Newswire
TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
NewsAug 10, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsAug 6, 8:06 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsAug 6, 7:05 AM ET
Evolent Health Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $652.520M Beat $597.997M Estimate
Press releaseAug 6, 7:00 AM ETPRNewswire
Evolent Announces Second Quarter 2026 Results
Press releaseJul 8, 4:30 PM ETPRNewswire
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Press releaseMay 12, 7:00 AM ETPRNewswire
Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer
NewsMay 7, 7:02 AM ET
Evolent Health Q1 Adj. EPS $(0.02) Beats $(0.05) Estimate, Sales $496.246M Miss $534.669M Estimate.
Press releaseMay 7, 7:00 AM ETPRNewswire
Evolent Announces First Quarter 2026 Results
Press releaseApr 7, 4:30 PM ETPRNewswire
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
Press releaseMar 19, 8:45 AM ETPRNewswire
Evolent announces appointment of Archie Mayani as chief product officer
Press releaseMar 18, 9:11 AM ETPRNewswire
Foodsmart Appoints Cityblock Health Co-Founder and CEO Dr. Toyin Ajayi to Board of Directors
Press releaseFeb 26, 5:00 PM ETPRNewswire
Evolent to Participate in Upcoming Investor Conferences
NewsFeb 25, 8:01 AM ET
Evolent Health Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
NewsFeb 24, 4:11 PM ET
Evolent Health Q4 Adj. EPS $0.08 Beats $0.06 Estimate, Sales $468.719M Beat $468.701M Estimate
Press releaseFeb 24, 4:10 PM ETPRNewswire
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
NewsFeb 24, 6:11 AM ET
Earnings Scheduled For February 24, 2026
Press releaseFeb 4, 11:02 AM ETPRNewswire
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
NewsFeb 2, 7:00 AM ET
Deep Dive Into Evolent Health Stock: Analyst Perspectives (11 Ratings)
NewsJan 6, 8:01 AM ET
The Analyst Verdict: Evolent Health In The Eyes Of 9 Experts
Press releaseJan 2, 4:15 PM ETPRNewswire
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
Press releaseNov 11, 8:30 AM ETGlobe Newswire
Global Digital Health Market Size Projected to Reach $1.5 Trillion By 2032 as A.I. Technology Enhances Operations
Press releaseNov 6, 4:12 PM ETPRNewswire
Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
Press releaseNov 6, 4:10 PM ETPRNewswire
Evolent Announces Third Quarter 2025 Results
NewsNov 6, 6:12 AM ET
Earnings Scheduled For November 6, 2025
Press releaseOct 9, 8:30 AM ETPRNewswire
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
NewsSep 30, 8:02 AM ET
Forecasting The Future: 6 Analyst Projections For Evolent Health
Press releaseSep 23, 4:10 PM ETPRNewswire
Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
NewsSep 9, 8:01 AM ET
The Analyst Verdict: Evolent Health In The Eyes Of 4 Experts
Press releaseAug 19, 7:00 AM ETPRNewswire
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
Press releaseAug 18, 4:05 PM ETPRNewswire
Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
Press releaseAug 7, 4:10 PM ETPRNewswire
Evolent Announces Second Quarter 2025 Results
Press releaseJun 20, 6:30 AM ETPRNewswire
Evolent reiterates Q2 and full year guidance for Adjusted EBITDA
Press releaseMay 8, 4:10 PM ETPRNewswire
Evolent Announces First Quarter 2025 Results
Press releaseFeb 20, 4:10 PM ETPRNewswire
Evolent Announces Fourth Quarter and Full Year 2024 Results
NewsNov 8, 2:34 PM ETAvi Kapoor
S&P 500 Tops 6,000; Sezzle Shares Spike Higher

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026

TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation

TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Evolent Health Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $652.520M Beat $597.997M Estimate

Evolent Announces Second Quarter 2026 Results

Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer

Evolent Health Q1 Adj. EPS $(0.02) Beats $(0.05) Estimate, Sales $496.246M Miss $534.669M Estimate.

Evolent Announces First Quarter 2026 Results

Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026

Evolent announces appointment of Archie Mayani as chief product officer

Foodsmart Appoints Cityblock Health Co-Founder and CEO Dr. Toyin Ajayi to Board of Directors

Evolent to Participate in Upcoming Investor Conferences

Evolent Health Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Evolent Health Q4 Adj. EPS $0.08 Beats $0.06 Estimate, Sales $468.719M Beat $468.701M Estimate

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results

Earnings Scheduled For February 24, 2026

Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026

Deep Dive Into Evolent Health Stock: Analyst Perspectives (11 Ratings)

The Analyst Verdict: Evolent Health In The Eyes Of 9 Experts

Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

Global Digital Health Market Size Projected to Reach $1.5 Trillion By 2032 as A.I. Technology Enhances Operations

Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden

Evolent Announces Third Quarter 2025 Results

Earnings Scheduled For November 6, 2025

Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Forecasting The Future: 6 Analyst Projections For Evolent Health

Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners

The Analyst Verdict: Evolent Health In The Eyes Of 4 Experts

Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Evolent Announces Second Quarter 2025 Results

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA

Evolent Announces First Quarter 2025 Results

Evolent Announces Fourth Quarter and Full Year 2024 Results

S&P 500 Tops 6,000; Sezzle Shares Spike Higher